Literature DB >> 15356674

Cis-acting effect of the IL1B C-31T polymorphism on IL-1 beta mRNA expression.

R Kimura1, T Nishioka, A Soemantri, T Ishida.   

Abstract

Since the effect of IL1B polymorphisms on IL-1beta production is still controversial, we selected two polymorphisms to test their cis-acting effect on IL-1beta mRNA expression by means of the allele-specific transcript quantification and the haplotype analysis. As for the C-31T polymorphism, we found that expression of the -31T allele was 2.2 times of the -31C allele. This higher transcription efficiency may correspond to the fact that C-31T is located in a TATA box. The other polymorphism, C+3954T, did not alter the levels of transcription. The use of the allele-specific transcript quantification enables us to exclude trans-acting effects of polymorphisms on the gene expression and contributes to understanding the roles of the IL1B polymorphisms in susceptibility to multifactorial diseases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15356674     DOI: 10.1038/sj.gene.6364128

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  18 in total

1.  Gene Variant and Level of IL-1β in Ischemic Stroke Patients With and Without Type 2 Diabetes Mellitus.

Authors:  Khouloud Chehaibi; Mohamed Yahia Hrira; Imen Trabelsi; Juan Carlos Escolà-Gil; Mohamed Naceur Slimane
Journal:  J Mol Neurosci       Date:  2015-07-09       Impact factor: 3.444

2.  Association of innate immune single-nucleotide polymorphisms with the electroencephalogram during desflurane general anaesthesia.

Authors:  Claire Vignette Mulholland; Andrew Alexander Somogyi; Daniel Thomas Barratt; Janet Kristie Coller; Mark Rowland Hutchinson; Gregory Michael Jacobson; Raymond Thomas Cursons; James Wallace Sleigh
Journal:  J Mol Neurosci       Date:  2013-12-19       Impact factor: 3.444

Review 3.  Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease.

Authors:  Sara De Iudicibus; Raffaella Franca; Stefano Martelossi; Alessandro Ventura; Giuliana Decorti
Journal:  World J Gastroenterol       Date:  2011-03-07       Impact factor: 5.742

4.  The IL-1 gene family and bone involvement in celiac disease.

Authors:  M L Moreno; J B A Crusius; A Cherñavsky; E Sugai; A Sambuelli; H Vazquez; E Mauriño; A S Peña; J C Bai
Journal:  Immunogenetics       Date:  2005-09-29       Impact factor: 2.846

5.  A polymorphism of C-to-T substitution at -31 IL1B is associated with the risk of advanced gastric adenocarcinoma in a Japanese population.

Authors:  Sanae Kabata Ikehara; Yuzuru Ikehara; Keitaro Matsuo; Kaoru Hirose; Toru Niwa; Hidemi Ito; Seiji Ito; Yasuhiro Kodera; Yoshitaka Yamamura; Hayao Nakanishi; Masae Tatematsu; Kazuo Tajima
Journal:  J Hum Genet       Date:  2006-09-28       Impact factor: 3.172

6.  Significance of IL-1RA Polymorphism in Iranian Patients with Inflammatory Bowel Disease.

Authors:  Nasser Ebrahimi Daryani; Maryam Sadr; Shirin Moossavi; Sepideh Shahkarami; Samaneh Soltani; Elham Farhadi; Nima Rezaei
Journal:  Dig Dis Sci       Date:  2014-12-03       Impact factor: 3.199

7.  Polymorphic variability in the interleukin (IL)-1beta promoter conditions susceptibility to severe malarial anemia and functional changes in IL-1beta production.

Authors:  Collins Ouma; Gregory C Davenport; Gordon A Awandare; Christopher C Keller; Tom Were; Michael F Otieno; John M Vulule; Jeremy Martinson; John M Ong'echa; Robert E Ferrell; Douglas J Perkins
Journal:  J Infect Dis       Date:  2008-10-15       Impact factor: 5.226

8.  Common variants in interleukin-1-Beta gene are associated with intracranial hemorrhage and susceptibility to brain arteriovenous malformation.

Authors:  Helen Kim; Pirro G Hysi; Ludmila Pawlikowska; Annie Poon; Esteban González Burchard; Jonathan G Zaroff; Stephen Sidney; Nerissa U Ko; Achal S Achrol; Michael T Lawton; Charles E McCulloch; Pui-Yan Kwok; William L Young
Journal:  Cerebrovasc Dis       Date:  2008-12-18       Impact factor: 2.762

9.  Variation in IL10 and other genes involved in the immune response and in oxidation and prostate cancer recurrence.

Authors:  Paul J Dluzniewski; Ming-Hsi Wang; Siqun Lilly Zheng; Angelo M De Marzo; Charles G Drake; Helen L Fedor; Alan W Partin; Misop Han; M Daniele Fallin; Jianfeng Xu; William B Isaacs; Elizabeth A Platz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-08-02       Impact factor: 4.254

10.  Interleukin-1beta promoter (-31T/C and -511C/T) polymorphisms in major recurrent depression.

Authors:  Paulina Borkowska; Krzysztof Kucia; Szymon Rzezniczek; Monika Paul-Samojedny; Malgorzata Kowalczyk; Aleksander Owczarek; Renata Suchanek; Tomasz Medrala; Jan Kowalski
Journal:  J Mol Neurosci       Date:  2011-04-05       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.